NTPF ready to restore funding to Beaumont Hospital when it receives ‘assurances over use'
National Treatment Purchase Fund
(NTPF) is ready to restore funding for insourcing initiatives to tackle waiting lists at
Beaumont Hospital
when it receives sufficient assurances regarding its appropriate use, the organisation's chairman Don Gallagher is to tell the Dáil
Public Accounts Committee
today.
The provision of such NTPF funding for Beaumont has been paused since April on foot of what were described as 'potential financial irregularities'.
The
HSE
this week defined insourcing as the practice of engaging external companies or third-party providers to deliver services often outside of normal working hours using public-owned facilities and equipment. It often employs existing healthcare personnel on premium rates.
In an opening statement to the Dáil Public Accounts Committee on Thursday, Mr Gallagher will say that upon learning of 'potential issues in relation to NTPF-funded insourcing work at Beaumont Hospital, it immediately suspended all insourcing work and payments at Beaumont and informed the Department of Health and HSE of its concerns'.
READ MORE
He will say that HSE internal auditors are currently carrying out a detailed review in Beaumont.
'We are ready and willing to recommence insourcing in Beaumont once we receive the necessary assurance regarding the appropriate use of NTPF funds. We are working closely with the HSE regional executive office on this matter.'
'The public must have full confidence and trust in the insourcing process. We are working alongside the Department of Health and HSE to increase governance and oversight across our insourcing work with public hospitals.'
The Irish Times reported last month that the catalyst for the suspension of funding for insourcing initiatives was a letter sent by consultants in one specialty to the chairwoman of Beaumont. The letter maintained the hospital had billed the NTPF for about 1,400 patients over a number of years who had actually been seen at regular public clinics.
On Wednesday, Fiona Brady, chief executive of the NTPF, told the Oireachtas Joint Committee on Health that the
letter had been written by rheumatologists
at Beaumont Hospital.
She said the issue had emerged after she noticed in January that Beaumont Hospital had not applied for insourcing funding. It had received about €8 million the previous year.
Ms Brady said she had arranged a meeting with her counterpart at Beaumont at which she was shown a copy of the letter sent by the rheumatologists. She said subsequently a review of invoices submitted over a one-year period had been carried out.
'The NTPF had been billed as if it was additionality,' Ms Brady told the committee.
[
HSE chief tells Oireachtas group that 'we took our eye off the ball'
Opens in new window
]
The Public Accounts Committee is also expected on Thursday to question senior management at Children's Health Ireland (CHI), which runs paediatric hospitals in Dublin. Questioning is expected over an unpublished and highly controversial internal report from 2022 which questioned whether special weekend clinics funded by the NTPF in one specialty had been needed.
The NTPF suspended funding for insourcing initiatives at CHI for a period in May and early June after details of the 2022 report were leaked. The funding was later restored.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Times
43 minutes ago
- Irish Times
Gallagher quit Nutribrand after firm decided to change chairman, says presidential hopeful Sheridan
Former presidential candidate Seán Gallagher resigned from his role at Nutribrand after it decided to replace him as chairman, the company's chief executive, Gareth Sheridan , has said. Mr Sheridan, who announced his own bid for the presidency over the weekend, said the company was 'surprised' when Mr Gallagher raised the issue of a basketball corporate box in his January 2022 resignation letter. The 35-year-old pharma businessman from Terenure in Dublin intends to run as an independent candidate, seeking a nomination from local authorities to get on the ballot paper. Mr Sheridan cofounded US-based Nutribrand in 2012, which utilises technology to prevent the abuse of patch medications such as fentanyl. READ MORE Mr Gallagher, another Irish businessman who came second in the presidential race of 2011, became chairman of Nutribrand in 2018. However, according to Mr Sheridan, Mr Gallagher resigned from the role in January 2022 when communications broke down over a change in corporate structure. A spokesman for Mr Sheridan said Mr Gallagher's resignation came shortly after the company decided his role should be filled by 'someone with US capital markets experience'. It was decided that Serguei Melnik, a cofounder of Nutribrand, would be appointed chairman and that Mr Gallagher would 'voluntarily vacate' the role and remain as director on the same remuneration package. 'Communication broke down at this point,' the spokesman said, and Mr Gallagher submitted a resignation in January 2022. The spokesman said the company was 'surprised' when Mr Gallagher referenced a corporate box in his resignation letter. In 2020 the company paid $180,000 for a corporate box from basketball team Orlando Magic at the Amway Arena Stadium in Florida, for a renewable one-year period. The company described it as a 'good fit' because 'it is the NBA's most prominent team in the fight against the misuse of opioids'. Nutribrand retains this corporate box and has extended its contract, the spokesman said. Also declared as presidential contenders are former MEP Mairead McGuinness, selected as Fine Gael's candidate, and Independent TD for Galway West Catherine Connolly, who has support from Oireachtas members. No other parties have announced candidates as yet.
Irish Independent
an hour ago
- Irish Independent
HSE condemns racist attacks and says health services could not operate without international staff
It follows a spate of attacks on people from the immigrant community here in recent weeks. In a statement the HSE said the effective operation of many essential health services in Ireland would be seriously threatened without the support of the many thousands of international staff that work in our hospitals and community services every day. Healthcare professionals from India, Africa and other Asian countries account for 23pc of HSE nurses and midwives 'The HSE is proud of the organisation's diverse workforce, all of whom are critical for provision of services for patients across Ireland.' Anne Marie Hoey, Chief People Officer of the HSE, said, 'The HSE unequivocally condemns all incidents of racist abuse and assaults of people from abroad, their families and the wider community. It is unacceptable. People should not be afraid to leave their house or go to work for fear of abuse. 'We are proud of our organisation's diversity and are dependent on all our staff for the delivery of frontline, essential services. Ensuring the safety of all employees and service users is a priority for the HSE. We are committed to creating a safe environment within which to work or to be treated. 'We are deeply grateful to international workers who have chosen to move their lives and families to Ireland to work with the HSE and help provide essential care and support for patients. We are saddened to hear reports that some international staff, now fearful for their personal safety, are considering moving away. This will have a dramatic impact on staff levels and the provision of health services and should be a cause for alarm for people in this country.' The HSE added that it actively supports the workforce through a range of policies, continuing to prioritise the management of work-related aggression and violence to support the organisation's strategy and policy. Key focus areas are the national policy on the management of work-related aggression and violence (policy review), risk assessment and training. 'The Dignity at Work Policy aims to provide a safe working environment for all employees in the public health service which recognises the right to be treated with dignity and respect, and which is free from all forms of bullying, harassment and sexual harassment.'
Irish Times
6 hours ago
- Irish Times
Glanbia increases full-year earnings guidance despite slump in profit
Nutritionals group Glanbia has increased its earnings forecast for the year while appointing a new chairman. The company, which has been struggling to contend with a spike in the cost of whey proteins, a key input, said headline revenue for the first six months of the year increased by 6 per cent to $1.9 billion. Profits, however, were down by 7.5 per cent to $132 million. The company also announced the sale of its Dutch e-commerce platform Body&Fit for an undisclosed sum while noting there was 'no news yet' on the planned sale of its underperforming dieting brand SlimFast. READ MORE The Dublin-listed group upgraded its full-year earnings guidance to 130-133 cent per share, up from 124-130 cent, as a result of what it described as 'increased revenue momentum' in the second quarter across its performance nutrition (PN) division. The PN element of the business has been the star performer n recent years but it has been hit by a jump in the cost of whey. The company unveiled Paul Duffy, a former chairman and chief executive of Pernod Ricard North America, as chair designate to replace Donal Gaynor who is due to step down from the role at the end of the year. 'Today's results reflect a first half of significant execution and progress as we generated 6 per cent revenue growth in the period, underpinned by strong growth in health & nutrition (H&N) and dairy nutrition (DN) and a sequential improvement in performance nutrition through the period as the group navigated significant macroeconomic volatility,' chief executive Hugh McGuire said. 'We are today upgrading our full year adjusted EPS guidance to 130 to 133 cent as a result of increased revenue momentum in PN and improved margins in H&N,' he said. 'The category trends remain positive, and we expect to see continued improvement in volumes across PN in the second half of the year with continued momentum in H&N and DN,' he said.
